Aqueous stability of recombinant human thrombopoietin as a function of processing schemes

Journal of Pharmaceutical Sciences

Volumn 85, Issue 7, 1996, Pages 749-752

  Senderoff, Richard I ^a   Kontor, Kathleen M ^a   Heffernan, Jane K ^a   Clarke, Holly J ^a   Garrison, Lori K ^a   Kreilgaard, Lotte ^a   Lasser, Gerald W ^a   Rosenberg, Gary B ^a  

^a ZYMOGENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSORBATE 80; PROTEINASE; PROTEINASE INHIBITOR; RECOMBINANT THROMBOPOIETIN;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; DRUG DEGRADATION; DRUG FORMULATION; DRUG PURIFICATION; DRUG STABILITY; DRUG STORAGE; MOUSE; NONHUMAN; PH; PROTEIN DEGRADATION; PROTEIN PROCESSING; RECEPTOR AFFINITY;

EID: 0030037636     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js950377g     Document Type: Article

References (18)

1. Oeswein, J. Q.; Shire, S. J. In Peptide and Protein Drug Delivery; Lee, V., Ed.; Marcel Dekker: New York, 1991; pp 167-203.
2. Stability and Characterization of Protein and Peptide Drugs; Wang, Y. J., Pearlman, R., Eds.; Plenum Press: New York, 1993; Vol. 5.
3. Chen, T. Drug Dev. Ind. Pharm. 1992, 18 (11, 12), 1311-1354.
4. Foster, D. C.; Sprecher, C. A.; Grant, F. J.; Kramer, J. M.; Kuijper, J. L.; Holly, R.D.; Whitmore, T. E.; Heipel, M. D.; Bell, L. A.; Ching, A. F. T.; McGrane, V.; Hart, C.; O'Hara, P. J.; Lok, S. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 13023-13027.
5. Metcalf, D. Nature 1994, 369, 519-520.
6. de Sauvage, F. J.; Hass, P. E.; Spencer, S. D.; Malloy, B. E.; Gurney, A. L.; Spencer, S. A.; Darbonne, W. C.; Henzel, W. J.; Wong, S. C.; Kuang, W.-J.; Oles, K. J.; Hultgren, B.; Solberg, L. A., Jr.; Goeddel, D. V.; Eaton, D. L. Nature 1994, 369, 533-538.
7. Lok S.; Kaushansky, K.; Holly, R. D.; Kuijper, J. L.; Lofton-Day, C. E.; Oort, P. J.; Grant, F. J.; Heipel, M. D.; Burkhead, S. K.; Kramer, J. K.; Bell, L. A.; Sprecher, C. A.; Blumberg, H.; Johnson, R.; Prunkard, D.; Ching, A. F. T.; Mathewes, S. L.; Bailey, M. C.; Forstrom, J. W.; Buddle, M. M.; Osborn, S. G.; Evans, S. J.; Sheppard, P. O.; Presnell, S. R.; O'Hara, P. J.; Hagen, F. S.; Roth, G. J.; Foster, D. C. Nature 1994, 369, 565-568.
8. Kaushansky, K.; Lok, S.; Holly, R. D.; Broudy, V. C.; Lin,N.; Bailey, M. C.; Forstrom, J. W.; Buddle, M. M.; Oort, P. J.; Hagen, F. S.; Roth, G. J.; Papayannopoulou, T.; Foster, D. C. Nature, 1994, 369, 568-571.
9. Wendling, F.; Maraskovsky, E.; Debili, N.; Florindo, C.; Teepe, M.; Titeux, M.; Methia, N.; Breton-Gorius, J.; Cosman, D.; Vainchenker, W.; Nature 1994, 369, 571-574.
10. Vigon, L. M.; Mornon, J.-P.; Cocault, L.; Mitjavila, M.-T.; Tambourin, P.; Gisselbrecht, S.; Souyri, M. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 5640-5644.
11. Vigon, L. M.; Florindo, C.; Fichelson, S.; Guenet, J.-L.; Mattei, M.-G.; Souyri, M.; Cosman, D.; Gisselbrecht, S. Oncogene 1993, 8, 2607-2615.
12. Skoda, R. C.; Seldin, D. C.; Chiang, M.-K.; Piechel, C. L.; Vogt, T. F.; Leder, P.; EMBO J. 1993, 12, 2645-2653.
13. Palacios, R.; Steinmetz, M. Cell 1985, 41, 727-734.
14. Senderoff, R. I.; Wooton, S. C.; Boctor, A. M.; Chen, T.-M.; Giordani, A. B.; Julian, T. J.; Radebaugh, G. W. Pharm. Res. 1994, 11 (12), 1712-1720.
15. Baneyx, F.; Georgiou G.; In Stability and Characterization of Protein and Peptide Drugs, Ahern, T. J.; Manning, M. C. (eds.), Plenum Press: New York, 1993; Vol. 2, pp 69-108.
16. Satoh, M.; Hosoi, S.; Sato, S. In Vitro Cell. Dev. Biol. 1990, 26, 1101-1104.
17. Lind, W.; Lietz, M.; Jager, V.; Wagner, R. In Animal Cell Culture and Production of Biologicals; Sasaki, R., Ikura, K., Eds.; Kluwer Academic Publishers: Dordrecht, 1991; pp 319-327.
18. North, M, J. In Proteolytic Enzymes. A Practical Approach; Beynon, R. J., Bond, J. S., Eds.; IRL Press: Oxford, 1990; pp 105-124.